Literature DB >> 9923692

Structure-function relationships of antimicrobial peptides.

P M Hwang1, H J Vogel.   

Abstract

Antimicrobial peptides are ubiquitously produced throughout nature. Many of these relatively short peptides (6-50 residues) are lethal towards bacteria and fungi, yet they display minimal toxicity towards mammalian cells. All of the peptides are highly cationic and hydrophobic. It is widely believed that they act through nonspecific binding to biological membranes, even though the exact nature of these interactions is presently unclear. High-resolution nuclear magnetic resonance (NMR) has contributed greatly to knowledge in this field, providing insight about peptide structure in aqueous solution, in organic cosolvents, and in micellar systems. Solid-state NMR can provide additional information about peptide-membrane binding. Here we review our current knowledge about the structure of antimicrobial peptides. We also discuss studies pertaining to the mechanism of action. Despite the different three-dimensional structural motifs of the various classes, they all have similar amphiphilic surfaces that are well-suited for membrane binding. Many antimicrobial peptides bind in a membrane-parallel orientation, interacting only with one face of the bilayer. This may be sufficient for antimicrobial action. At higher concentrations, peptides and phospholipids translocate to form multimeric transmembrane channels that seem to contribute to the peptide's hemolytic activity. An understanding of the key features of the secondary and tertiary structures of the antimicrobial peptides and their effects on bactericidal and hemolytic activity can aid the rational design of improved analogs for clinical use.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9923692     DOI: 10.1139/bcb-76-2-3-235

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  69 in total

1.  Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations.

Authors:  Craig M Shepherd; Hans J Vogel; D Peter Tieleman
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Cationic hydrophobic peptides with antimicrobial activity.

Authors:  Margareta Stark; Li-Ping Liu; Charles M Deber
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 3.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 4.  Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.

Authors:  E Andrès
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-01       Impact factor: 3.267

5.  Insights on the interactions of synthetic amphipathic peptides with model membranes as revealed by 31P and 2H solid-state NMR and infrared spectroscopies.

Authors:  Marise Ouellet; Geneviève Bernard; Normand Voyer; Michèle Auger
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

6.  Application of 'inductive' QSAR descriptors for quantification of antibacterial activity of cationic polypeptides.

Authors:  Artem Cherkasov; Bojana Jankovic
Journal:  Molecules       Date:  2004-12-31       Impact factor: 4.411

7.  Structure-function studies of Bubalus bubalis lingual antimicrobial peptide analogs.

Authors:  Dhruba Jyoti Kalita; Ashok Kumar; Satish Kumar
Journal:  Vet Res Commun       Date:  2008-07-24       Impact factor: 2.459

8.  Tapioca Starch Modulates Cellular Events in Oral Probiotic Streptococcus salivarius Strains.

Authors:  Rafig Gurbanov; Hazel Karadağ; Sevinç Karaçam; Gizem Samgane
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

Review 9.  S. Typhimurium strategies to resist killing by cationic antimicrobial peptides.

Authors:  Susana Matamouros; Samuel I Miller
Journal:  Biochim Biophys Acta       Date:  2015-01-30

10.  De novo design of potent antimicrobial peptides.

Authors:  V Frecer; B Ho; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.